COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,157 Articles (22,703 medRxiv, 8,454 bioRxiv)

Most recent first Previous |  Page 176: Articles 1751-1760  | Next

The Impact of Preprints on the Citations of Journal Articles Related to COVID-19
Tsunoda, H., Sun, Y., Nishizawa, M., Liu, X., Amano, K., Kominami, R.
10.1101/2024.07.21.604465 — Posted: 2024-07-23
Demultiplexing and barcode-specific adaptive sampling for nanopore direct RNA sequencing
van der Toorn, W., Bohn, P., Liu-Wei, W., Olguin-Nava, M., Smyth, R. P., von Kleist, M.
10.1101/2024.07.22.604276 — Posted: 2024-07-23
SARS-CoV-2 dynamics in New York City during March 2020 - August 2023
Yang, W., Parton, H., Li, W., Watts, E. A., Lee, E., Yuan, H.
10.1101/2024.07.19.24310728 — Posted: 2024-07-22
Trajectory of severe COVID anxiety and predictors for recovery in an 18-month cohort.
King, J. D., McQuaid, A., Barnicot, K., Basett, P., Leeson, V. C., Di Simplicio, M., Tyrer, P., Tyrer, H., Watt, R. G., Crawford, M. J.
10.1101/2024.07.22.24310664 — Posted: 2024-07-22
Combining individual and wastewater whole genome sequencing improves SARS-CoV-2 surveillance
Troendle, E. P., Lee, A. J., Reyne, M. I., Allen, D. M., Bridgett, S. J., Radulescu, C. H., Glenn, M., Wilkins, J.-P., Rubino, F., Firoozi Nejad, B., McSparron, C., Niebel, M., Fairley, D. J., Creevey, C. J., McKinley, J. M., Skvortsov, T., McGrath, J. W., Bamford, C. G. G., Simpson, D. A.
10.1101/2024.07.22.24310067 — Posted: 2024-07-22
Epidemiological Parameters of SARS-CoV-2 in the UK during the 2023/2024 Winter: A Cohort Study
Overton, C. E., Fyles, M., Mellor, J., Paton, R. S., Phillips, A. M., Glaser, A., Charlett, A., Ward, T.
10.1101/2024.07.22.24310801 — Posted: 2024-07-22
Brains Under Stress: Unravelling the Effects of the COVID-19 Pandemic on Brain Ageing
Mohammadi-Nejad, A.-R., Craig, M., Cox, E., Chen, X., Jenkins, R. G., Francis, S., Sotiropoulos, S., Auer, D. P.
10.1101/2024.07.22.24310790 — Posted: 2024-07-22
Analysis of B-cell receptor repertoire to evaluate the immunogenicity of SARS-CoV-2 RBD mRNA vaccine: MAFB-7256a (DS-5760d)
Ohji, G., Funakoshi, Y., Yakushijin, K., Matsutani, T., Sasaki, T., Kusakabe, T., Matsumoto, S., Koyama, T., Nagatani, Y., Kurata, K., Kimbara, S., Kiyota, N., Minami, H.
10.1101/2024.07.19.24310697 — Posted: 2024-07-21
Biguanides Associate with Decreased Early Mortality and Risk of Acute Kidney Injury In Hospitalized COVID-19 Patients: a nationwide retrospective cohort study in Japan
Sugimoto, M., Kikuchi, H., Sohara, E., Limbutara, K., Hirakawa, A., Mori, T., Susa, K., Oya, S., Suzuki, T., Iimori, S., Fushimi, K., Uchida, S.
10.1101/2024.07.20.24310736 — Posted: 2024-07-21
Rapid Detection of Active Coronavirus Infection by Lateral Flow Test Strips: A New Approach to Distinguish Replicating Viruses from Non-Replicating Viruses
Davis, D., Lamb, C. H., Myhrvold, C. A., Ullah, H.
10.1101/2024.07.18.604218 — Posted: 2024-07-19

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).